肺部由SARS-CoV-2感染引起的病变的形态病理学
Florin Ionuţ Buibaş1, Roberta Andreea Cercel, Mircea Sebastian Şerbănescu
1Doctoral School, University of Medicine and Pharmacy of Craiova, Romania; cercelroberta@gmail.com.
概括
尸检显示COVID-19患者的严重肺损伤,包括炎症,出血和纤维化. 这些发现有助于解释2019年冠状病毒病 (COVID-19) 死亡中出现的呼吸系统衰竭.
科学领域:
- 肺病理学 肺病理学
- 法医医学法医学的医学.
- 传染性疾病传染性疾病.
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 导致全球大流行,导致冠状病毒疾病2019 (COVID-19).
- COVID-19主要影响肺部,导致呼吸衰竭,肺栓塞,二次性肺炎和纤维化.
- 由于SARS-CoV-2引起的器官损伤的确切机制仍然不太清楚.
研究的目的:
- 为了调查死去的COVID-19患者的肺病变.
- 为了将肺病理与急性呼吸困扰综合征 (ARDS) 的复杂症状相关联.
- 为了阐明SARS-CoV-2引起的肺损伤的病原性.
主要方法:
- 在法律上可疑的情况下死亡的36名COVID-19患者的解剖检查.
- 肺组织的组织病理学分析,以确定炎症和纤维变化.
- 对血管病变,血栓形成和组织重塑的评估.
主要成果:
- 所有患者都表现出肺炎炎症反应与排泄和增殖现象.
- 重要发现包括膜内和间歇性炎症透物 (淋巴细胞,巨细胞,中性粒细胞).
- 观察到血管堵塞/破裂,出血,血栓,纤维细胞增殖,肌纤维细胞转化和颗粒组织形成,导致肺膜重塑.
结论:
- 该研究详细介绍了COVID-19死亡人群中广泛的肺病变,与ARDS一致.
- 研究结果强调炎症,血管损伤,血栓形成和纤维化是关键的病理特征.
- 观察到的肺病理学提供了关于COVID-19严重呼吸衰竭背后的机制的见解.
相关概念视频
Pneumonia II: Pathophysiology
204
The pathophysiology of pneumonia involves the following steps:
204
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Pulmonary Tuberculosis II
210
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
210


